Bio2RDF uri
Gamma Interferon Therapy for Chronic Hepatitis C [clinicaltrials:NCT00028275]clinicaltrials:NCT0005686212 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy. [clinicaltrials:NCT00069511]4-Methylumbelliferone as a Treatment for Chronic HBV/HCV [clinicaltrials:NCT00225537]Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study [clinicaltrials:NCT00466271]Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices [clinicaltrials:NCT00466336]clinicaltrials:NCT00475176clinicaltrials:NCT00630084clinicaltrials:NCT00803309Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma [clinicaltrials:NCT00834860]Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection [clinicaltrials:NCT01771653]
reference [clinicaltrials_vocabulary:reference]
Bio2RDF identifier
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/pubmed:11439948
identifiers.org URI
citation [clinicaltrials_vocabulary:citation]
Lauer GM, Walker BD. Hepatitis ...... 01 Jul 5;345(1):41-52. Review.
identifier
pubmed:11439948
title
11439948
@en
label
11439948 [pubmed:11439948]
@en